Comorbidities | T2D | Hyperlipidemia | Hypertension | Obesity | Insulin resistance | Metabolic syndrome | CVD | Depression | Hypothyroid | CKD |
---|---|---|---|---|---|---|---|---|---|---|
Total (n = 2,312) | 56% | 50% | 46% | 42% | 27% | 17% | 15% | 11% | 9% | 8% |
F0 (n = 189) | 42% | 33% | 29% | 32% | 22% | 12% | 5% | 9% | 5% | 1% |
F1 (n = 576) | 47% | 39% | 40% | 30% | 22% | 15% | 10% | 10% | 9% | 3% |
F2 (n = 843) | 59% | 55% | 49% | 42% | 29% | 18% | 14% | 11% | 8% | 6% |
F3 (n = 486) | 63% | 58% | 55% | 56% | 31% | 19% | 20% | 13% | 9% | 14% |
F4 (n = 218) | 64% | 52% | 49% | 56% | 29% | 22% | 25% | 21% | 13% | 22% |